Neoprobe (NEOP) Completes Name Change to 'Navidea Biopharmaceuticals'
Tweet
Share
E-mailGet Alerts NEOP Hot Sheet
Join SI Premium – FREE
Neoprobe Corporation (Nasdaq: NEOP) today announced that it has completed its corporate name change to Navidea Biopharmaceuticals, Inc. (Amex: NAVB). The Company will begin trading under the ticker symbol, NAVB, on the NYSE Amex at market open today. The CUSIP number for NAVB common stock has also been changed to 63937X103.
The Navidea name and logo represent the Company’s dedication to “NAVigating IDEAs” that translate cutting edge innovation and precision diagnostics technology into novel products to advance patient care.
The Navidea name and logo represent the Company’s dedication to “NAVigating IDEAs” that translate cutting edge innovation and precision diagnostics technology into novel products to advance patient care.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Philip Morris (PM) beats Q1 earnings, revenue estimates; issues upbeat guidance
- Nordson Corp. (NDSN) Appoints Daniel Hopgood as CFO
- Sonos (SONO) Unveils Completely Reimagined Sonos App
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
